SKIP TO CONTENT
Johns Hopkins
  • Home
  • About
  • News
  • Contact
  • Login

    • New therapy kickstarts immune response to cancer

    New therapy kickstarts immune response to cancer

    Cancer researchers with Johns Hopkins All Children’s Hospital successfully boosted immune response to cancer tissue in a study that could dramatically improve survival and prevent tumor relapse.

    LEARN MORE
    SEE ALL NEWS
    Recent Posts
    Prostate Cancer: Advancements in Screening Experimental KRAS Vaccine Generates Immune Response Against Pancreatic Cancer in People at High Risk Newly Identified Inhibitors May Boost Chemotherapy Drug’s Ability to Fight Treatment-Resistant Cancers Virtual Tumor Predict Response to Liver Cancer Immunotherapy Ovarian Cancer Researcher Wins Prestigious Lotus Award Blocking Energy Metabolism May Help Treat Aggressive Pediatric Brain Tumor This new drug could change how we treat one of the deadliest cancers Inherited Long Telomeres May Drive Broad Risk for Lymphoid Cancers How a Division I athlete who never smoked turned his stage 4 ALK+ lung cancer diagnosis into a fight for a cure
    Johns Hopkins

    2026 © The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.
    Terms of Use Privacy Statement

    LinkedIn
    Back to top